NL-OMON41595已完成4 期
Immune monitoring to characterize T-cell responses of kidney transplant patients during co-stimulation blockade by belatacept - Characterizing T-cell responses during belatacept treatment
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 41
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •a) Male or female kidney transplant recipients.
- •b) Age >= 18 years.
- •c) Patients to be transplanted with a first or second kidney allograft.
- •d) Patients receiving a kidney allograft from a living donor.
- •e) Patients receiving a bloodgroup AB0-compatible kidney transplant.
- •f) Patients receiving a non-HLA identical kidney transplant.
- •g) Panel reactive antibodies (PRA) <30%.
- •h) Patients must have known EBV serostatus, and that status must be positive.
- •i) Patients receiving a non-HLA-DR mismatched kidney transplant.
排除标准
- •a) Recipients of a third (or higher) allograft.
- •b) Recipients of a non-renal organ transplant.
- •c) Recipients of a kidney transplant from a deceased donor.
- •d) Recipients under the age of 18 years.
- •e) Sensitized transplant recipients (defined as a PRA of >=30%).
- •f) Recipients of a HLA-identical kidney allograft.
- •g) Recipients of a bloodgroup AB0-incompatible kidney allograft.
- •h) Recipients with a historically positive cross-match.
- •i) Patients with a history of lymphoma.
- •j) Seronegative or unknown EBV serostatus.
- •k) Patients with tuberculosis who have not been treated for (latent) infection.
- •l) Patients at high risk for polyoma virus-associated nephropathy.
- •m) Patients receiving an HLA-DR mismatched kidney transplant.
研究者
相似试验
进行中（未招募）
不适用
The immune response during treatment with belatacept after kidney transplantation.EUCTR2012-003169-16-NLErasmus MC, University Medical Center Rotterdam
已完成
不适用
An initial study to determine the T lymphocyte response in seriously ill COVID-19 patients: An observational study in Pune, IndiaCTRI/2021/03/032028Dr D Y Patil Vidyapeeth Pune137
尚未招募
不适用
Post vaccination immunological response and immune monitoring for SARS-CoV-2CTRI/2021/08/035338Medanta Institute of Education and Research
已完成
不适用
Cellular & Serological Immune Response Monitoring in SARS-CoV2-infected individuals, without need of hospitalizatioCorona virusCOVID-191004743810024970NL-OMON50071eids Universitair Medisch Centrum10
已完成
不适用
A pilot study to characterize T cell responses in young children after influenza infectio10047438influenzaNL-OMON33577niversitair Medisch Centrum Utrecht125